Reinhart Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Reinhart Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-20,000	Closed	-$14K	–	199
2015 Q1	$14K	Hold	20,000	–	–	﹤0.01%	191
2014 Q4	$16K	Hold	20,000	–	–	﹤0.01%	184
2014 Q3	$9K	Hold	20,000	–	–	﹤0.01%	174
2014 Q2	$10K	Hold	20,000	–	–	﹤0.01%	177
2014 Q1	$6K	Hold	20,000	–	–	﹤0.01%	164
2013 Q4	$7K	Hold	20,000	–	–	﹤0.01%	172
2013 Q3	$40K	Buy	+20,000	New	+$38.1K	﹤0.01%	178

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Reinhart Partners's GCVRZ Position: Q2 2015 in Review

Reinhart Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2015, closing a stake of 20,000 shares — an estimated $14K sold.

Reinhart Partners first reported a position in GCVRZ in Q3 2013 and held it in 7 quarters. The position peaked at $40K in Q3 2013. 116 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2015.

Reinhart Partners reported no remaining Sanofi Contingent Value Rights position as of Q2 2015 after selling out during the quarter.
Reinhart Partners sold 20,000 Sanofi Contingent Value Rights shares in Q2 2015, an estimated $14K.
Reinhart Partners first reported a position in Sanofi Contingent Value Rights in Q3 2013 and held it in 7 quarters.
Reinhart Partners's Sanofi Contingent Value Rights position peaked at $40K in Q3 2013.
116 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2015.

Based on Reinhart Partners's 13F filing for Q2 2015, filed 7 Jul 2015.